Stock RCEL AVITA MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AVITA Medical, Inc.

Equities

RCEL

US05380C1027

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
8.07 USD +3.59% Intraday chart for AVITA Medical, Inc. +1.89% -41.18%
Jul. 02 Avita Medical Appoints Chief Legal and Compliance Officer MT
Jul. 01 Avita Medical Names Chief Legal, Compliance Officer MT

Evolution of the average Target Price on AVITA Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0b7c5e064ed4.60rI0Str6Sj2lOY3n4bkZl6Mwo886uOG-OulrF9MPxM.xhuwmV8Roxqv8LR83rHRUBvt8txLvdrKtaHC4xgNfCSCOauaEimFd5Hz3g~0a4bec854510bd0565964920508cfdb1

Analyst Recommendations on AVITA Medical, Inc.

Cantor Fitzgerald Trims Price Target on Avita Medical to $21 From $22, Maintains Overweight Rating MT
Piper Sandler Downgrades Avita Medical to Neutral From Overweight, Price Target is $9 MT
Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 MT
BTIG Research Downgrades Avita Medical to Neutral From Buy MT
Piper Sandler Raises Price Target on Avita Medical to $21 From $19, Maintains Overweight Rating MT
Cantor Fitzgerald Adjusts Price Target on Avita Medical to $22 From $20, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
11.97 AUD
Average target price
34.91 AUD
Spread / Average Target
+191.74%
High Price Target
60.24 AUD
Spread / Highest target
+403.49%
Low Price Target
13.62 AUD
Spread / Lowest Target
+13.85%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AVITA Medical, Inc.

Cantor Fitzgerald
Piper Sandler
Wilsons
BTIG

Ratings for AVITA Medical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RCEL Stock
  4. Consensus AVITA Medical, Inc.